forecast

GLP-1 Class Could Exceed $100B Revenue

GLP-1 medicines will easily be in excess of $100 billion a year in revenue, and their adoption has exceeded almost everyone's expectations, including the speaker's own.

forecastpending

Speaker

Alex

Evidence Quote

“this as a class of medicines will easily be in excess of $100 billion a year in revenue”

Source

Alex Karnal - The Trillion-Dollar Health Revolution - [Invest Like the Best, EP.468]— Invest Like the Best
Created: 11/14/2026, 4:24:39 AM

Your notes

Loading notes...